Literature DB >> 26815256

Percutaneous Endoscopic Lumbar Discectomy as an Alternative to Open Lumbar Microdiscectomy for Large Lumbar Disc Herniation.

Kyung Chul Choi, Jin-Sung Kim, Choon-Keun Park1.   

Abstract

BACKGROUND: Remarkable advancements in endoscopic spinal surgery have led to successful outcomes comparable to those of conventional open surgery. Large lumbar disc herniation (LLDH) is a serious condition, resulting in higher surgical failure when accessing the herniated disc.
OBJECTIVES: This study compared the outcomes of LLDH treated with percutaneous endoscopic lumbar discectomy (PELD) and open lumbar microdiscectomy (OLM). STUDY
DESIGN: Retrospective assessment.
METHODS: This retrospective observational study was conducted from January 2011 to June 2012. Forty-four consecutive patients diagnosed with LLDH without cauda equina syndrome who were scheduled to undergo spinal surgery were included. LLDH was defined as herniated disc fragment occupying > 50% of the spinal canal. Clinical outcomes were evaluated using a visual analogue scale (VAS, 0 - 10), functional status was assessed using the Oswestry Disability Index (ODI, 0 - 100%) at 1, 6, and 24 months postoperatively and surgical satisfaction rate (0 - 100%) at final follow up. Radiological variables were assessed by plain radiography.
RESULTS: Forty-three patients were included; 20 and 23 patients underwent PELD and OLM, respectively. Both groups exhibited significant improvements in leg and back pain postoperatively (P < 0.001). Although there was no significant difference in leg pain improvement between the groups, improvement in back pain was significantly higher in the PELD group than in the OLM group (4.9 ± 1.5 vs. 2.5 ± 1.0, P < 0.001). The surgical satisfaction rate of the PELD group was significantly higher than that of the OLM group (91.3% ± 6.5 vs. 84.3% ± 5.2, P < 0.001). Mean operating time, hospital stay, and time until return to work were significantly shorter in the PELD group than in the OLM group (67.8 vs. 136.7 minutes, 1.5 vs. 7.2 days, and 4.2 vs. 8.6 weeks; P < 0.001). Disc height (%) decreased significantly from 23.7 ± 3.3 to 19.1 ± 3.7 after OLM (P < 0.001), but did not change significantly after PELD (23.6 ± 3.2 to 23.4 ± 4.2; P = 0.703). The segmental angle of the operated level increased from 10.3° to 15.4° in the PELD group, which was significantly higher than that in the OLM group (9.6° to 11.6°; P = 0.038). In the OLM group, there was one case of fusion due to instability. In the PELD group, one case required revision surgery and another case experienced recurrence. There were no perioperative complications in either group. LIMITATION: The study was retrospective with a small sample size and short follow-up period.
CONCLUSION: PELD can be an effective treatment for LLDH, and it is associated with potential advantages, including a rapid recovery, improvements in back pain, and disc height preservation.

Entities:  

Mesh:

Year:  2016        PMID: 26815256

Source DB:  PubMed          Journal:  Pain Physician        ISSN: 1533-3159            Impact factor:   4.965


  35 in total

1.  Percutaneous endoscopic lumbar discectomy for LDH via a transforaminal approach versus an interlaminar approach: a meta-analysis.

Authors:  Yongjing Huang; Jianjian Yin; Zhenzhong Sun; Sheng Song; Yin Zhuang; Xueguang Liu; Shihao Du; Yongjun Rui
Journal:  Orthopade       Date:  2020-04       Impact factor: 1.087

2.  Consideration of proper operative route for interlaminar approach for percutaneous endoscopic lumbar discectomy.

Authors:  Juichi Tonosu; Yasushi Oshima; Ryutaro Shiboi; Akihiko Hayashi; Yuichi Takano; Hirohiko Inanami; Hisashi Koga
Journal:  J Spine Surg       Date:  2016-12

Review 3.  [Operative treatment of degenerative diseases of the lumbar spine].

Authors:  M Czabanka; C Thomé; F Ringel; B Meyer; S-O Eicker; V Rohde; M Stoffel; P Vajkoczy
Journal:  Nervenarzt       Date:  2018-06       Impact factor: 1.214

4.  Clinical Application of Large Channel Endoscopic Systems with Full Endoscopic Visualization Technique in Lumbar Central Spinal Stenosis: A Retrospective Cohort Study.

Authors:  Shuo Han; Xiangxu Zeng; Kai Zhu; Xiaoqi Wu; Yanqing Shen; Jialuo Han; Antao Lin; Shengwei Meng; Hao Zhang; Guanghui Li; Xiaojie Liu; Hao Tao; Xuexiao Ma; Chuanli Zhou
Journal:  Pain Ther       Date:  2022-09-03

5.  Percutaneous Endoscopic Lumbar Discectomy Using a Double-Cannula Guide Tube for Large Lumbar Disc Herniation.

Authors:  Hongwei Wang; Hong Yuan; Hailong Yu; Changqing Li; Yue Zhou; Liangbi Xiang
Journal:  Orthop Surg       Date:  2022-06-03       Impact factor: 2.279

6.  [Percutaneous endoscopic transforaminal unilateral decompression for treatment of lumbar spinal stenosis and observational study of non-surgical lower extremity symptoms].

Authors:  Ziquan Li; Keyi Yu; Yipeng Wang; Jianguo Zhang
Journal:  Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi       Date:  2019-07-15

7.  Significance and pitfalls of percutaneous endoscopic lumbar discectomy for large central lumbar disc herniation.

Authors:  Mikihito Kondo; Yasushi Oshima; Hirokazu Inoue; Yuichi Takano; Hirohiko Inanami; Hisashi Koga
Journal:  J Spine Surg       Date:  2018-03

8.  Endoscopic and Microscopic Interlaminar Discectomy for the Treatment of Far-Migrated Lumbar Disc Herniation: A Retrospective Study with a 24-Month Follow-Up.

Authors:  Fei Yang; Liangjuan Ren; Qingqing Ye; Jianhua Qi; Kai Xu; Rigao Chen; Xiaohong Fan
Journal:  J Pain Res       Date:  2021-06-04       Impact factor: 3.133

9.  Evaluation of Transforaminal Endoscopic Discectomy in Treatment of Obese Patients with Lumbar Disc Herniation.

Authors:  Ya-Peng Wang; Wei Zhang; Ji-Long An; Jian Zhang; Jia-Yue Bai; Ya-Peng Sun
Journal:  Med Sci Monit       Date:  2016-07-18

10.  Percutaneous Endoscopic Interlaminar Discectomy with Modified Sensation-Motion Separation Anesthesia for Beginning Surgeons in the Treatment of L5-S1 Disc Herniation.

Authors:  Meng Kong; Changtong Gao; Wenbin Cong; Guanghui Li; Chuanli Zhou; Xuexiao Ma
Journal:  J Pain Res       Date:  2021-07-08       Impact factor: 3.133

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.